Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4165768
Max Phase: Preclinical
Molecular Formula: C55H92N12O13
Molecular Weight: 1129.41
Molecule Type: Small molecule
Associated Items:
ID: ALA4165768
Max Phase: Preclinical
Molecular Formula: C55H92N12O13
Molecular Weight: 1129.41
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)O
Standard InChI: InChI=1S/C55H92N12O13/c1-28(2)24-39(60-35(12)69)50(75)58-32(9)47(72)62-41(26-30(5)6)52(77)61-38(16-13-14-22-56)49(74)64-42(27-36-18-20-37(70)21-19-36)53(78)63-40(25-29(3)4)51(76)59-33(10)48(73)66-45(34(11)68)55(80)67-23-15-17-43(67)54(79)65-44(31(7)8)46(57)71/h18-21,28-34,38-45,68,70H,13-17,22-27,56H2,1-12H3,(H2,57,71)(H,58,75)(H,59,76)(H,60,69)(H,61,77)(H,62,72)(H,63,78)(H,64,74)(H,65,79)(H,66,73)/t32-,33-,34+,38-,39-,40-,41-,42-,43-,44-,45-/m0/s1
Standard InChI Key: GNBPKAOYKASKSS-FQONXFRWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1129.41 | Molecular Weight (Monoisotopic): 1128.6907 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Chen X, Liu L, Chen Y, Yang Y, Yang CY, Guo T, Lei M, Sun H, Wang S.. (2018) Cyclic Peptidic Mimetics of Apollo Peptides Targeting Telomeric Repeat Binding Factor 2 (TRF2) and Apollo Interaction., 9 (5): [PMID:29795768] [10.1021/acsmedchemlett.8b00152] |
Source(1):